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Abstract
Background Transcranial Doppler (TCD) has been used to
estimate ICP noninvasively (nICP); however, its accuracy
varies depending on different types of intracranial hyper-
tension. Given the high specificity of TCD to detect
cerebrovascular events, this study aimed to compare four
TCD-based nICP methods during plateau waves of ICP.
Methods A total of 36 plateau waves were identified in 27
patients (traumatic brain injury) with TCD, ICP, and ABP
simultaneous recordings. The nICP methods were based
on: (1) interaction between flow velocity (FV) and ABP
using a ‘‘black-box’’ mathematical model (nICP_BB); (2)
diastolic FV (nICP_FVd); (3) critical closing pressure
(nICP_CrCP), and (4) pulsatility index (nICP_PI). Anal-
yses focused on relative changes in time domain between
ICP and noninvasive estimators during plateau waves and
the magnitude of changes (D between baseline and plateau)
in real ICP and its estimators. A ROC analysis for an ICP
threshold of 35 mmHg was performed.
Results In time domain, nICP_PI, nICP_BB, and
nICP_CrCP presented similar correlations: 0.80 ± 0.24,
0.78 ± 0.15, and 0.78 ± 0.30, respectively. nICP_FVd
presented a weaker correlation (R = 0.62 ± 0.46). Corre-
lations between DICP and DnICP were better represented
by nICP_CrCP and BB, R = 0.48, 0.44 (p < 0.05),
respectively. nICP_FVd and PI presented nonsignificant D
correlations. ROC analysis showed moderate to good areas
under the curve for all methods: nICP_BB, 0.82;
nICP_FVd, 0.77; nICP_CrCP, 0.79; and nICP_PI, 0.81.
Conclusions Changes of ICP in time domain during pla-
teau waves were replicated by nICP methods with strong
correlations. In addition, the methods presented high per-
formance for detection of intracranial hypertension.
However, absolute accuracy for noninvasive ICP assess-
ment using TCD is still low and requires further
improvement.
Keywords Transcranial Doppler  Noninvasive ICP 
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Introduction
Acute intracranial hypertension (ICH) is a recurrent cause
of secondary injury in patients under neurocritical care.
Intracranial pressure (ICP) represents an essential moni-
toring modality in the correct clinical management of
several neurological diseases carrying risk of potentially
lethal ICH. ICP is a complex variable, consisting of four
components modulated by different physiological mecha-
nisms: (1) inflow and volume of arterial blood, (2) venous
blood outflow, (3) cerebrospinal fluid (CSF) circulation,
and (4) brain parenchymal or lesion volume. The impor-
tance of ICP is not always associated with its absolute
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value, but with monitoring of its dynamics in time and with
identifying which of the above mentioned components are
responsible for the observed pattern of ICH [1]. This is
essential, as every component that elevates ICP requires
different countermeasures (like short-term hyperventilation
to control 1; head elevation to control 2; extra ventricular
drainage to control 3; osmotherapy or craniectomy to
control component 4).
First described by Janny [2] in 1950 and later by
Lundberg [3], plateau waves of ICP (or Lundberg A waves)
[3] are characterized by sudden and relevant increases in
ICP (generally above 40 mmHg [4]), related to increased
volume of arterial blood in response to arterial vasodilation
stimulus. Such phenomena may develop in patients pre-
senting intact cerebral autoregulation [4] and low
cerebrospinal compensatory reserve [5], suffering from a
wide range of cerebral pathological conditions including
traumatic brain injury (TBI) [4], idiopathic intracranial
hypertension [6], subarachnoid hemorrhage [7], brain
tumors, hydrocephalus [8], and craniosynostosis [9].
During the occurrence of plateau waves, ICP increases
from normal or slightly elevated to uncompensated, acute
ICH, with relatively stable arterial blood pressure (ABP)
[10]. The mechanism driving plateau waves can be
described as a ‘‘vasodilatory cascade,’’ initiated by a
vasodilatory stimulation (reduction in ABP during intact
autoregulation, for instance) [4]. Following this, a rapid
increase in cerebral blood volume (CBV) leads to a cyclic
rise in ICP, decrease in cerebral perfusion pressure (CPP),
further vasodilation and further rise of ICP. This cycle is
maintained until the cerebral vasculature reaches a state of
maximum vasodilation [10]. The reverse of this positive
feedback loop occurs when a vasoconstrictive stimulus
initiates a vasoconstrictive cascade, decreasing CBV with a
consequent drop in ICP toward normal levels [10, 11].
Transcranial Doppler ultrasonography (TCD), owing to
its specificity to detect changes in cerebrovascular
dynamics [12], offers non-quantitative measurements of
cerebral blood flow (CBF). CBF is the blood supply to the
brain in a given period of time, and global changes in this
parameter can be monitored continuously and noninva-
sively using TCD-derived cerebral blood flow velocity
(FV) [13]. CBV and CBF are usually correlated, as CBV
equals CBF multiplied by the cerebral vascular mean
transit time [14]. Some studies have demonstrated that
specific patterns of FV waveform reflect inadequate cere-
bral perfusion caused by a decrease in CPP [15, 16] (as it
occurs during plateau waves, for instance). In such cases,
ICP increases lead to decreases in CPP by closing arterioles
at higher diastolic pressures, thus causing remarkable drops
in diastolic flow velocity (FVd). Consequently, there is a
generalized decrease in mean flow velocity (FVm). These
characteristics observed in the FV waveform pattern can be
used as indicators of cerebral perfusion derangements and
have been applied as variables for noninvasive ICP esti-
mations [17]. However, the inherent difficulty of ICP
estimation in such a scenario is the lack of reliable indi-
vidual calibration of estimators in appropriate units
(mmHg).
Although it has been shown that different TCD-based
nICP estimators present with different measures of accu-
racy [18], there are reports suggesting that these methods
are more accurate when changes of ICP are related to
vasogenic phenomena [19, 20]. Considering these
assumptions, the aim of this study was to assess a set of
four previously described TCD-based nICP methods in a
cohort of patients who presented changes in ICP purely of
vasogenic origin (specifically plateau wave increases of
ICP) to verify whether these methods reliably predict ICP
under such conditions.
Methods
Patients
From a database of 446 adult TBI patients [median age of
patients: 30 years (interquartile range (IQR) 18–78, with
75% being male), with simultaneous recordings of ABP,
ICP, and TCD, 27 patients were identified where at least
one plateau wave occurred during the monitoring period.
Plateau waves were identified as sudden and spontaneous
increases in ICP (and pulse amplitude of ICP), during
which CPP and FVm dropped with a relatively stable ABP.
A total of 36 plateau waves were identified during the TCD
monitoring and retrospectively analyzed for the purpose of
this study. The mean length of plateau waves was 13 min
with a range of 2–30 min. TBI data were recorded during
routine clinical TCD investigations of cerebral autoregu-
lation on the Neurosciences Critical Care Unit at
Addenbrooke’s Hospital, Cambridge UK (included in
Protocol 30 REC 97/290), and at the Universidad de la
Repu´blica School of Medicine Hospital, Montevideo,
Uruguay (one recording, with approval of the local ethical
committee). The retrospective analysis was performed as
part of an anonymous clinical audit.
Monitoring and Data Analysis
ABP was invasively monitored from the radial artery with
a pressure monitoring kit (Baxter Healthcare CA, USA;
Sidcup, UK), zeroed at the level of the heart. ICP was
monitored using an intraparenchymal probe (Cod-
man&Shurtleff or Camino), and FV was monitored
exclusively from the M1 segment of the middle cerebral
artery through the temporal window with a 2-MHz probe
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and the Doppler Box (DWL Compumedics) or Neuroguard
(Medasonic) TCD devices. The probe was held in place
during the entire recording using a head band or frame
provided by the TCD device manufacturer. TCD moni-
toring was ordered routinely in every patient after TBI to
assess the state of cerebral autoregulation. The TCD
recordings with simultaneous ABP and ICP were per-
formed for periods of 10 min to 1 h by MC, PS and CP.
ICP management was not stopped during the TCD
recordings, but occasional artifacts (such as ABP flushes
and ICP increases generated by suctions) were cleaned out.
Raw signals were digitized using an analog–digital
converter (DT2814, Data Translation) sampled at a fre-
quency of 50 Hz and recorded using in-house designed
software (separate in Cambridge and Montevideo) and later
retrospectively analysed using ICM+ software (Cambridge
Enterprise, http://www.neurosurg.cam.ac.uk/icmplus/).
The recorded signals were subjected to manual artifacts
removal.
All the calculations, including mean values of ABP,
ICP, FV, were performed over a 10-s long-sliding window.
The minimal and maximum values of FV from every 2-s
period were calculated and treated as end diastolic and
peak systolic (FVs) components, respectively. These com-
ponents were then averaged over 10 s to give the mean
values for FVd and FVs.
Noninvasive ICP Methods
1. Schmidt et al. ‘‘black-box’’ (BB) model [21]
(nICP_BB):
It is described in terms of a transfer function between ABP
and ICP [22, 23], controlled by TCD- and ABP-derived
parameters. The rules of this TCD-based linear control had
been formerly determined using a multiple regression
model between TCD parameters and ABP-ICP transfer
function on datasets of reference patients (N = 140, TBI).
The model provides continuous full waveform of nICP (in
mmHg).
2. Czosnyka et al. [16] (nICP_FVd):
It applies the diastolic flow velocity waveform analysis
for the estimation of nCPP (noninvasive CPP). nICP can be
calculated as the difference between mean ABP (ABPm)
and nCPP (nICP = ABPm - nCPP).
nICP ¼ ABPm  1 FVd
FVm
 
 14mmHg ð1Þ
14 mmHg is the zero compensation factor established in a
cohort of TBI patients [16].
3) Varsos et al. [24] (nICP_CrCP):
Similarly, it calculates nICP based on nCPP, in this case
specifically using the concept of critical closing pressure
(CrCP) [24].
nCPP ¼ ABPm
 0:734 0:266ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
CVR Ca HR 2pð Þ2þ1
q
2
64
3
75
 7:026 mmHg
ð2Þ
CVR ¼ ABP
FV
ð3Þ
Ca ¼ CaBV Amp
ABP Amp
ð4Þ
CVR (mmHg/(cm/s)) represents cerebral vascular resis-
tance, Ca (cm/mmHg) denotes the compliance of the
cerebral arterial bed assuming a non-pulsatile venous blood
outflow [25], and HR expresses heart rate (beats/s), with
ABP and FV as the required measurements for the calcu-
lation of these parameters. CaBV Amp represents the
fundamental amplitude of the cerebral arterial blood
Table 1 Median values (IQR)
of the differences between
plateau and baseline phase (D
[mmHg]), D correlations with
ICP, correlations in time
domain for all assessed methods
and area under ROC curve for
detection of ICP above
35 mmHg
Method D R (DICP vs. DnICP) R (time domain) AUC (95% CI)
nICP_BB 9.00 (13.18–5.05) 0.44* 0.78 ± 0.15 0.82 (0.71–0.93)
nICP_FVd 10.10 (17.74–4.56) 0.19 0.62 ± 0.46 0.77 (0.65–0.88)
nICP_CrCP 2.89 (4.12–2.11) 0.48* 0.78 ± 0.30 0.79 (0.67–0.91)
nICP_PI 2.82 (5.20–1.92) 0.30 0.80 ± 0.24 0.81 (0.70–0.91)
ICP 24.49 (26.72–21.19) – –
DICP and DnICP distributions are significantly different in all cases. AUC prediction estimators for each
nICP method considering the threshold of 35 mmHg. ICP intracranial pressure, nICP_BB estimator based
on a black-box mathematical model, nICP_FVd estimator based on the diastolic cerebral blood flow
velocity, nICP_CrCP estimator based on the concept of critical closing pressure, and nICP_PI estimator
based on the pulsatility index
* Spearman correlation coefficient is significant at the 0.05 level
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volume, calculated from FV waveform using a model of
non-pulsatile cerebral blood outflow [26]. ABP Amp rep-
resents the fundamental amplitude of arterial blood
pressure. Finally, nICP can be obtained as the difference
between ABP and nCPP (nICP = ABP - nCPP). Constant
coefficients (0.734, 0.266, 7.026 mmHg) are derived from
analysis of database of retrospective cases (N = 232, TBI)
[24].
nICP_PI
Pulsatility index (PI) describes changes in the morphology
of the FV waveform. It is a relationship between the dif-
ference of FVs and FVd divided by FVm (Eq. 5). The
estimation formula for nICP_PI originated from the linear
regression between ICP and PI from a population cohort of
292 TBI patients [27] (Eq. 6).
PI ¼ FVs  FVd
FVm
ð5Þ
nICP ¼ 4:47 PI þ 12:68mmHg ð6Þ
Statistical Analysis
Statistical analysis of the data was conducted with R Studio
software (R version 3.1.2). Data were tested for normal
distribution using the Shapiro–Wilk test. All plateau waves
were treated as independent phenomena. The analysis
included Spearman correlations between DICP and DnICP
(D correlations) and averaged correlations for variations of
nICP across time during the course of plateau waves. ‘‘D’’
(magnitude) represents the difference between plateau (at
the top of plateau waves) and baseline (before the onset of
plateau waves) mean values in each recording. R symbol-
izes the Spearman correlation coefficient, with the level of
significance set at 0.05.
The area under the curve (AUC) of the receiver oper-
ating characteristic curve (ROC) was performed to
determine the ability of the noninvasive methods to detect
raised ICP during plateau waves (using a threshold of
35 mmHg). This threshold was chosen considering the
high values of ICP observed during both phases of plateau
waves. In this case, 35 mmHg represents mathematically
Fig. 1 Example of recordings showing reliable and unreliable
replications of a plateau waves of ICP by TCD-based nICP methods
(panels a and b, respectively). On Y axis, mean absolute values of
ICP and nICPs are presented; and on X axis, relative changes of ICP
and nICPs in time domain
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half way between baseline and plateau phases ICP values.
The predicting ability is considered reasonable when the
AUC is higher than 0.7 and strong when the AUC exceeds
0.8 [28]. Statistical differences between ROC curves were
verified using the DeLong’s test for two correlated ROC
curves (R package pROC [29]).
Results
In 27 patients, a total of 36 plateau waves were identified (7
patients presented two plateau waves, and one patient
presented 3 plateau waves). Table 1 presents correlations
(DR) between DICP and DnICP and averaged correlations
in time domain.
Correlations in time domain are independent of mean
values of ICP or nICP and represent the ability of a nICP
method to replicate relative changes observed in direct ICP
across time. In average, correlations in time were reason-
ably good, with R > 0.60 for all methods. nICP_PI,
nICP_BB, and nICP_CrCP presented similar averaged
correlations in time (R C 0.78). Examples of good and
poor correlations between ICP and nICP during plateau
waves are shown in Fig. 1.
Correlations between DICP and DnICP were better
represented by nICP_CrCP and nICP_BB, while the other
methods presented inferior and nonsignificant correlations
(Fig. 2). All DnICP mean values were significantly
underestimated in comparison with DICP.
Table 1 also contains the prediction values for each
nICP method according to the ROC analysis. The best
AUC value for predicting intracranial hypertension (i.e.,
ICP C 35 mmHg) was presented by nICP_PI. Neverthe-
less, all methods presented AUC above 0.7, an indication
of reasonable prediction abilities for detecting ICH. The
DeLong’s test for two correlated ROC curves did not
reveal any statistically significant difference between nICP
methods. The ICP thresholds yielding the best sensitivity
and specificity were 27.41 mmHg (AUC = 0.86),
28.42 mmHg (AUC = 0.79), 23.08 mmHg (AUC = 0.75),
and 20.28 mmHg (AUC = 0.84), respectively, for
nICP_BB, FVd, CrCP, and PI, respectively.
nICP_CrCP and nICP_PI presented null values for
specificity and negative predictive value, indicating that
Fig. 2 Correlations plot between DICP and DnICP for all methods. (asterisk) Spearman correlation coefficient is significant at the 0.05 level
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values of these two estimators during plateau waves were
always below 35 mmHg (although they reacted to rise in
ICP, a remarkable underestimation of real pressure was
observed). Nevertheless, all methods presented good pos-
itive predictive values (65, 69, 58, and 58% for nICP_BB,
FVd, CrCP, and PI, respectively), which otherwise would
indicate that many of the positive results were false
positives.
Table 2 presents the median values (IQR) for the
physiological variables evaluated during baseline and pla-
teau phases. During plateau waves, ICP (and ICP pulse
amplitude—ICP Amp) increased and CPP decreased sig-
nificantly, whereas ABP remained unchanged. FVm and
FVd presented significant decreases, whereas FVs increased
significantly. This resulted in significant increase in PI and
decrease in CVR. As the only nICP method provides ICP
waveform, nICP_BB presented increased pulse amplitude
(nICP_BB Amp), even with replication of the characteristic
triangular waveform shape observed during plateau waves
[30] (Fig. 3). The correlation between DICP Amp and
DnICP_BB Amp was significant (R = 0.50, p < 0.05);
however, nICP_BB Amp was significantly underestimated
in comparison with ICP Amp during plateau phase
(Bias = -2.88 mmHg, p < 0.05).
Discussion
In this work, we present the results of an assessment of a
set of TCD-based nICP methods in a cohort of patients
with changes in ICP purely of vasogenic origin (i.e., pla-
teau waves of ICP). Within the evaluated methods, only
nICP_BB and nICP_CrCP presented significant correla-
tions with DICP. On the other hand, changes in ICP
recorded in time were confidently replicated by all
methods.
Changes of ICP in time domain have been assessed in
other clinical conditions, and it appears to be highly
accurate when changes in ICP are of vasogenic origin. For
instance, during CSF infusion tests a controlled and artifi-
cial increase in CSF circulation causes an elevation in ICP
similar to the pattern observed during plateau waves.
Nevertheless, the correlations in time domain obtained with
the same nICP methods were considerably weaker [19] in
comparison with those observed here, where ICP changes
were specifically related to increases in cerebral arterial
blood volume. Moreover, such findings were not better
replicated when another TBI cohort was analyzed [31], in
which changes in ICP across time were not always related
to vasogenic waves.
For a better understanding of the results, we compared
the accuracy measures of the assessed methods in different
clinical conditions related to ICP increase (plateau waves,
CSF infusion tests [18], and TBI [31]). The 95% confi-
dence interval for nICP estimation is around 18 mmHg
during plateau waves and 15 mmHg in infusion studies,
while in TBI it is remarkably smaller, 9.4 mmHg. The
black-box model is the best one across these three clinical
scenarios. The correlation coefficient in time domain
between real and estimated ICP is greatest during plateau
waves (around 0.8, except for nICP_FVd [0.63]). For
infusion studies, the correlation is much lower (between
0.3 and 0.4 for nICP_BB, FVd, and CrCP). In TBI, the
correlation is between 0.5 to 0.6, but only for black-box
and PI-based methods.
In respect to ICP accuracy, it is known that even the
standard invasive techniques might not present the speci-
fied limits for error [32–34], particularly using
intraparenchymal microtransducers. Thus, it is debat-
able whether these accuracy requirements are realistic for
all sorts of ICP monitoring. In view of this, an important
concept that should be stressed is ICP not solely ‘‘as a
number,’’ once dynamical features of this parameter, such
as its waveform and relative changes in time, are funda-
mental for a proper assessment of the clinical state of the
patient [35].
The nICP black-box model had been previously ana-
lyzed during plateau waves of ICP [20]. In that study,
Table 2 Median (IQR) values for all physiological variables esti-
mated during baseline and plateau, with their respective D
correlations with DICP and DABP
Variable Baseline Plateau
ICP 22.81 (28.49–19.91) 46.45 (55.22–40.64)*
ABP 93.34 (98.30–86.14) 93.55 (97.44–85.28)
HR 75.72 (84.91–65.42) 74.73 (80.45–66.14)*
CPP 70.89 (78.22–60.38) 45.91 (52.87–37.17)*
FVm 57.31 (71.87–43.16) 45.52 (63.96–33.15)*
FVs 109.35 (132.35–92.78) 113.55 (141.72–99.44)*
FVd 31.04 (40.24–23.26) 22.99 (36.60–10.97)*
PI 1.39 (1.68–1.21) 2.00 (2.83–1.68)*
CVR 1.23 (1.47–1.00) 0.99 (1.25–0.68)*
CBV Amp 2.38 (3.73–1.82) 3.36 (4.77–2.42)*
CrCP 51.37 (56.88–41.89) 65.33 (70.67–52.07)*
ICP Amp 2.21 (2.58–1.70) 6.16 (7.88–4.90)*
nICP_BB Amp 1.97 (2.70–1.61) 3.44 (4.07–2.67)*
ABP arterial blood pressure (mmHg), CBV Amp cerebral blood vol-
ume amplitude (mmHg), CPP cerebral perfusion pressure (mmHg),
CrCP critical closing pressure (mmHg), CVR cerebral vascular
resistance (mmHg*s/cm), FV cerebral blood flow velocity (m,
mean; s, systolic; d, diastolic) (cm/s), HR heart rate (beats/min), ICP
Amp pulse amplitude of ICP (mmHg), nICP_BB Amp amplitude of
non-invasive ICP based on the black box model, PI pulsatility index
* At the 0.05 level, distributions between baseline and plateau are
significantly different
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clinical material from 17 patients was used to construct the
ICP simulation model, which produced better accuracy and
better correlation between real and estimated values of ICP
in comparison with our present study. This discrepancy
could be associated with the way nICP_BB was generated
in both studies. In Schmidt et al.’s previous study [20], the
formation dataset was much more specific for plateau
waves, in which 7 patients (41.18% of the dataset) pre-
sented such phenomena. On the other hand, the formation
dataset used for the present study consisted of a large
general TBI cohort (n = 140 patients), as mentioned
previously.
In this regard, we could generally infer that nICP
methods based on formation datasets specific for certain
conditions may present better prediction performances than
those based on general datasets. An example supporting
this inference can be found in another study [31], which
demonstrated that the same methods used here presented
smaller 95% CI when analyzing a TBI cohort convergent to
the formation datasets, i.e., general in terms of different
sources of ICP changes. However, the obvious disadvan-
tage of specific formation datasets is the restriction of
applicability of the nICP method. This effect was observed
when TBI dataset-generated nICP procedures were used for
ICP assessment in an NPH cohort subjected to CSF infu-
sion tests [19]. In that study, the use of non-specific nICP
formation datasets resulted in rather large deviations from
ICP.
Although the evaluated methods generally presented
low correlations considering the magnitude of changes in
ICP as an absolute value, not all clinical situations
involving ICP monitoring may require high accuracy.
Alternatively, TCD allows a noninvasive assessment of
cerebral circulation dynamics as ICP changes in time
domain, with the possibility to track nICP changes in real
time in a variety of clinical settings (emergency rooms,
ambulatories, operating theatres). This ability is one of the
gains of using TCD for nICP monitoring, and it could
potentially be applied as an alternative assessment or
screening tool where ICP measurements are not part of a
standard clinical protocol, or in situations which invasive
ICP monitoring is contraindicated.
Plateau waves affect approximately 25% of TBI patients
[10] and might also occur in other conditions such as
subarachnoid hemorrhage [7], brain tumors, hydrocephalus
[8], and craniosynostosis [9]. The identification of these
phenomena could represent an important application of
TCD-based noninvasive ICP methods for the conditions
Fig. 3 Example of plateau wave recording with direct ICP and
simulated ICP (nICP_BB). In comparison with baseline phase, at the
top of plateau waves nICP_BB presented an increased pulse
amplitude, in agreement with ICP. The characteristic triangular shape
of ICP waveform with three distinctive peaks observed during plateau
waves was replicated by nICP_BB
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aforementioned, as plateau waves have been also reported
to be associated with poor outcome in TBI patients, espe-
cially in regard to their duration [10]. Thus, identifying
plateau waves as nICP changes in time domain could
eventually provide to the clinician a better understanding of
the clinical state of the patient and guide oriented treat-
ments in situations of sustained plateau waves.
Limitations
The use of radial artery ABP zeroed at the level of the heart
instead of the blood pressure in the intracranial compart-
ment can be considered a limitation to this study. This
condition might non-accurately approximate peripheral to
intracranial ABP, which can specifically change the accu-
racy of methods relying on ABP waveform analysis.
However, heart level zeroing was part of the clinical pro-
tocol and could not be changed during the TCD recordings.
In addition, changes in cerebrovascular resistance produced
by variations in PaCO2 may disturb CPP estimation (nCPP)
and could act as a confounding factor as this parameter was
unavailable.
Conclusion
The methods of nICP assessment are remarkably accurate
in detecting relative changes in ICP during plateau waves
across time. Furthermore, they presented high performance
in ruling out intracranial hypertension. These characteris-
tics encourage the application of TCD-based nICP in
clinical conditions where the knowledge of absolute values
of ICP would not be essentially relevant. However, we
could infer that the estimation of ICP absolute values by
the nICP methods tested is still limited at the current state
of development. Such inaccuracy might be related to the
matter of non-specific nICP calibration.
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